Key result
Anakinra initiation after infliximab discontinuation is linked to progressive resolution of pericardial inflammation on CMR.
Why the study?
Pericardial involvement from infliximab-triggered drug-induced lupus is a rare presentation, and cardiac magnetic resonance can guide treatment and immunomodulatory tapering.
Case Report (n=1)
No
Longitudinal CMR is a valuable tool for tracking pericardial inflammatory activity and guiding the safe de-escalation of immunomodulatory therapy in biologic-induced autoimmune pericarditis.
Answers are grounded in this paper and cite their sources.
Longitudinal CMR may guide safe immunomodulatory de-escalation in autoimmune pericarditis; hypothesis-generating for biologic-induced cases.
Recurrent pericarditis is an uncommon extraintestinal manifestation of inflammatory bowel disease and may arise from biologic-induced autoimmunity. Anti–tumor necrosis factor (TNF) agents such as infliximab can trigger drug-induced lupus, with pericardial involvement representing a rare presentation. Cardiac magnetic resonance (CMR) enables precise evaluation of pericardial inflammation, guiding treatment strategies and supporting safe immunomodulatory tapering.
No takes yet. Share an insight, caveat, or question.
Mendpara et al. (2026) conducted a case report in Infliximab-induced systemic lupus erythematosus with recurrent pericarditis (n=1). Anakinra and colchicine (following infliximab discontinuation) was evaluated on Pericardial inflammatory activity assessed by serial cardiac magnetic resonance. Serial cardiac magnetic resonance imaging confirmed the progressive resolution of pericardial inflammation over five years following infliximab discontinuation and initiation of anakinra.
Synapse has enriched 10 related papers. Consider them for comparative context: